SciNeuro Pharmaceuticals
Developer of new drugs designed to transform the treatment of CNS diseases with a dedication that begins and ends with patients. The company's drugs have a strong CNS product pipeline through internal...
Valuation
$0
Share Price
N/A
Total Raised
$153M
Last Round
N/A